Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CACNG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR631 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAMD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00305 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC374443 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUX4L24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDE4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF333 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ONECUT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGLU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD104 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on